Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Cisplatin | Chemo | Chemotherapy | 5.1075 | 0.2490 | 0.0978 | 0.0114 | 1.4151 | 5.7965 | 0.99044 |
SK-BR-3 | Doxorubicin | Chemo | Chemotherapy | 0.0067336 | -0.6156 | 0.9421 | 0.3142 | 1.5278 | 0.010801 | 0.99572 |
SK-BR-3 | Taxol | Chemo | Chemotherapy | 0.0019068 | -0.3401 | 0.8905 | 0.3665 | 2.3888 | 0.0023578 | 0.96349 |
SK-BR-3 | Topotecan | Topo I | Chemotherapy | 0.016549 | -0.2711 | 0.7941 | 0.1919 | 1.9350 | 0.01923 | 0.98214 |
SK-BR-3 | Etoposide | Topo II | Chemotherapy | 0.39826 | -0.3169 | 0.4040 | 0.1186 | 1.5701 | 0.532 | 0.99524 |
SK-BR-3 | Dasatinib | BCR/ABL | MAPK/nRTK | 3.6452 | 0.0810 | 0.0617 | 0.0233 | 5.0000 | 3.5272 | 0.98252 |
SK-BR-3 | Trametinib | MEK | MAPK/nRTK | Inf | 0.6828 | 0.1817 | 0.0154 | 1.1257 | 0.0059643 | 0.93505 |
SK-BR-3 | Saracatinib | SRC | MAPK/nRTK | 4.9166 | 0.2786 | 0.0221 | 0.0102 | 5.0000 | 4.2128 | 0.96696 |
SK-BR-3 | ABT-737 | Bcl2/XL | Misc | Inf | 0.9470 | -0.0148 | 0.0045 | 0.0000 | Inf | 0.12804 |
SK-BR-3 | Vorinostat | HDAC | Misc | 0.7625 | -0.6322 | 0.3637 | 0.1534 | 2.3291 | 1.0657 | 0.99404 |
SK-BR-3 | Luminespib | HSP90 | Misc | 0.0022783 | -0.0766 | 0.7140 | 0.1099 | 2.5203 | 0.0024311 | 0.9977 |
SK-BR-3 | A-1210477 | Mcl-1 | Misc | 11.3859 | 0.6275 | 0.0389 | 0.0040 | 4.3303 | 10.9082 | 0.92796 |
SK-BR-3 | Olaparib | PARP | Misc | 12.0744 | 0.5653 | 0.0429 | 0.0174 | 1.0158 | 35.3887 | 0.93619 |
SK-BR-3 | Bleomycin | Radiation | Misc | 1.0576 | 0.1871 | 0.2604 | 0.0618 | 0.8229 | 0.85134 | 0.98455 |
SK-BR-3 | Ipatasertib | AKT | PI3K/mTOR | 3.3435 | 0.3560 | 0.1553 | 0.0254 | 0.8518 | 1.1231 | 0.9503 |
SK-BR-3 | Alpelisib | PI3Ka | PI3K/mTOR | 0.48468 | -0.1428 | 0.3788 | 0.0660 | 0.4911 | 2.8836 | 0.98115 |
SK-BR-3 | Taselisib | PI3Ka, g, d | PI3K/mTOR | 0.0061659 | -0.2068 | 0.8068 | 0.1477 | 0.6730 | 0.0081626 | 0.97463 |
SK-BR-3 | TGX221 | PI3Kb | PI3K/mTOR | Inf | 0.7496 | -0.0084 | 0.0076 | 4.9846 | 4.3561 | 0.86723 |
SK-BR-3 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.0036122 | -0.3416 | 0.7338 | 0.1751 | 1.3620 | 0.0050857 | 0.99744 |
SK-BR-3 | Everolimus | mTOR1 | PI3K/mTOR | -Inf | 0.1182 | 0.7944 | 0.1209 | 0.1000 | 6.3064e-07 | 0.84606 |
SK-BR-3 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.0026508 | -0.5064 | 0.9712 | 0.2693 | 1.0983 | 0.0044617 | 0.98817 |
SK-BR-3 | PF-4708671 | p70S6K | PI3K/mTOR | Inf | 0.7342 | 0.0214 | 0.0056 | 1.2557 | 6.3033 | 0.91227 |
SK-BR-3 | Buparlisib | pan PI3K | PI3K/mTOR | 0.13982 | -0.3731 | 0.5845 | 0.1589 | 0.9631 | 0.2774 | 0.98702 |
SK-BR-3 | Pictilisib | pan PI3K | PI3K/mTOR | 0.11448 | -0.1267 | 0.5120 | 0.0731 | 0.6701 | 0.17544 | 0.99532 |
SK-BR-3 | Ceritinib | ALK | RTK | 0.98319 | -0.8254 | 0.3174 | 0.0975 | 1.2454 | 2.3754 | 0.98337 |